Navigation Links
Eurofins MWG Operon and Genomatix launch strategic alliance
Date:7/8/2010

Eurofins MWG Operon, an expert in next generation sequencing (NGS) and Genomatix Software GmbH, a leading company in complex analysis and interpretation of such NGS data, announce their decision to combine their expertise and join forces to offer state-of-the art solutions for comprehensive genome analysis and re-sequencing project services.

"We are pleased to cooperate with a partner offering such a high level of expertise in understanding and interpretation of complex biological processes. The special know-how of Genomatix with its rich proprietary data background will have an enormous impact on our service offerings to our customers and will add a further layer of quality to strengthen our position as the leading provider for next generation sequencing services" says Bruno Poddevin, Eurofins Senior Vice President, Genomic Services.

Klaus May, Chief Business Officer of Genomatix, says: "Eurofins MWG Operon is an outstanding quality and service oriented company with friendly, bright and competent people. I am highly satisfied about this partnership, which represents the first one-stop-shop for complete project services, from experimental planning, wet-lab work and data analysis, to data interpretation and deep biological understanding. Together, we offer our customers cutting edge science and technology without the need for them to make major investments in equipment, infrastructure and manpower."

Both partners have already successfully worked together to gain several significant projects where applicative know-how and powerful bioinformatic capabilities have been key for effective project consulting and execution.


'/>"/>

Contact: Dr. Martin Seifert
seifert@genomatix.de
49-895-997-660
Genomatix Software GmbH
Source:Eurekalert

Page: 1

Related biology news :

1. Verizon Business to Provide Global IP for Eurofins Scientific
2. Genomatix gives a hand in the analysis of Wayne States sequencing projects
3. University of Michigan installs second Genomatix Genome Analyzer
4. MCTP bought Genomatix NextGen Sequencing analysis stations
5. Genomatix gets patent for comparative genomics method
6. CRG buys Genomatix Next Generation Sequencing analysis solution
7. Boehringer Ingelheim uses Genomatix Next Generation Sequencing data analysis systems
8. Genomatix joins Illumina-Connect program
9. Announcing launch of FRAX version 3.1
10. Ten years on, Wellcome Trust launches study of 10,000 human genomes in UK
11. American Sociological Association launches first-of-its-kind teaching tool
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... Calif. , March 21, 2017 ... analytics company serving law enforcement agencies, announced today the ... as director of public safety business development. ... diversified law enforcement experience, including a focus on the ... In his most recent position, Mr. Sheridan served as ...
(Date:3/16/2017)... Germany , March 16, 2017 CeBIT 2017 - Against identity ... Continue Reading ... Used combined in one project, multi-biometric solutions provide ... Used ... Systems) ...
(Date:3/9/2017)... MOUNTAIN VIEW, Calif. , March 9, 2017 ... and 23andMe , the leading personal genetics company, ... Zipongo can now provide customers with personalized nutrition plans ... and biometrics, but also genetic markers impacting how their ... Zipongo,s personalized food decision support platform uses biometrics such ...
Breaking Biology News(10 mins):
(Date:4/20/2017)... ... April 20, 2017 , ... ... a unique intellectual property (IP) sharing and commercialization model. , The Center for ... A main component of this effort is bringing the IP to the attention ...
(Date:4/19/2017)... ... 18, 2017 , ... The Vibrating Orifice Aerosol Generator (VOAG) ... monodisperse droplets of known diameters for research applications such as for calibrating droplet ... drying monodisperse droplets. , The VOAG requires forcing liquid out of an ...
(Date:4/19/2017)... ... , ... Nobilis Therapeutics Announces Completion of Landmark NBTX-001 Clinical Trial ... its Upcoming Post Traumatic Stress Disorder Trial , Nobilis Therapeutics, Inc. announced ... of its NBTX-001, a xenon-based therapeutic in the treatment of Panic Disorder. ...
(Date:4/19/2017)... PORTLAND, Oregon and PUNE, India , April 19, ... titled, "Membrane Microfiltration Market: Global Opportunity Analysis and Industry Forecast, 2014-2022 ," ... to garner $12,858 million by 2022, registering a CAGR of 9.6% from 2016 ... ... ...
Breaking Biology Technology: